Samsung Pharm (001360) — Long-term Investment Intensity
Samsung Pharm (001360) has a Long-term Investment Intensity of 14.0% as of September 2019. Long-term investments of ₩22.27 Billion represent 14.0% of total assets of ₩158.65 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check 001360 financial resilience to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Samsung Pharm Long-term Investment Intensity (2012–2018)
This chart shows how Samsung Pharm's Long-term Investment Intensity has evolved across 4 annual periods from 2012 to 2018. As of September 2019, the intensity stands at 14.0%, reflecting long-term investments of ₩22.27 Billion against total assets of ₩158.65 Billion KRW. For the complete balance sheet picture, see 001360 total assets.
Annual Long-term Investment Intensity for Samsung Pharm (2012–2018)
The table below presents the year-by-year Long-term Investment Intensity for Samsung Pharm from 2012 to 2018, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read total liabilities of Samsung Pharm for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (KRW) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 0.6% | ₩955.16 Million | ₩160.65 Billion | ▲ +0.3 pp |
| 2017 | 0.3% | ₩491.56 Million | ₩154.19 Billion | ▼ -0.6 pp |
| 2014 | 0.9% | ₩512.87 Million | ₩57.41 Billion | ▼ -0.8 pp |
| 2012 | 1.7% | ₩1.74 Billion | ₩103.02 Billion | — |